-
LPBI Group – Deals, Funding and Partnerships – Early Stage Start Ups in need for funding: Biologics, Small Molecules and Medical Devices
-
http://pharmaceuticalintelligence.com/joint-ventures/
HQS – Boston, MA
Funding, Deals & Partnerships
- Seven Types of Investment in Thirty Business Opportunities with GDE Enterprises
- Corporate Clients for our Services
- Funding Cardiovascular Medical Devices Development
- Funding Biologics Development
- Funding Diagnostics
- Funding Partnerships in IP Development
- M&A and Exit
- Targeting Penetration in New Markets for High Technology Products
- Modeling the Management of Intellectual Property Royalties
OUR CURRENT PLAN FOR FUNDING LPBI Group’s BUSINESS #2:
Deals, Funding and Partnerships
- 20 early stage start ups – Under discussion with two of our Investment Houses (NYC, Paris)
- NEW – Funding an Incubator, Tech-Innovate, Presentation by CEO, Mike Eisen, NDAs, continue negotiations
NEWS
- 9/28/2015 @9AM Skype with Haim Kravitz of AngelNet – Follow up meeting on 10/7
- Skype with P. Corne need be rescheduled
- 10/2 Skype with Antoine Loth, requested information on Excel File of Companies – Clients
- BY INVITATION ONLY — October 13th in Boston – Aviva accepted the invitation attend
the Visionary’s complimentary Investor Roundtables & ‘Meet Your Match’ Welcoming Receptions on Thursday September 24th in New York City (confirmed details below), and then October 13th in Boston, October 22nd in Los Angeles, and October 28th in San Francisco.
From: Janice Dru <janice@inkwhy.com>
Date: September 22, 2015 at 7:28:49 AM EDT
To: Aviva Lev-Ari <avivalev-ari@alum.berkeley.edu>
Subject: Exclusive Invitation to Visionary by Janice Dru
Dear Aviva,
As a member of the Visionary network founded by Princeton alumni, I have the privilege to invite you to Visionary’s complimentary Investor Roundtables & ‘Meet Your Match’ Welcoming Receptions on Thursday September 24th in New York City (confirmed details below), and then October 13th in Boston, October 22nd in Los Angeles, and October 28th in San Francisco.
The purpose of each event is to coordinate introductions among leading entrepreneurs, investors and executives at the forefront of their industry (Consumer, Entertainment, Health, Real Estate, Renewable Energy, Technology) who are seeking to connect with each other, exchange knowledge via Featured Presentations, and detail how to opt-in to Visionary’s matching process.
RSVP via rsvp@Visionary.is to confirm your desire to attend, specifying the name/date of the event. Visionary will respond with full venue, agenda, and matching process details. If now is not your best timing to take part, or if you wish to refer other exceptional individuals into Visionary as part of the Referral Exchange, please indicate that via the RSVP.
All the best to meet your matches in Visionary!
Regards,
Janice
**************************************
About: Visionary (www.Visionary.is) is a by-invitation-only business match making network arranging trusted meetings, supported to success, among leading entrepreneurs, investors, executives and subject matter experts (an exclusive, curated “eHarmony for business”).
– No fee to review/access meeting requests – Who are you seeking? www.visionaryaccess.net/survey
– On-demand access to others in the network via a tiered membership and referral exchange
– Founders’ Circle opportunity to take a stake and grow the network
Event: Visionary Investor Roundtables & ‘Meet Your Match’ Welcoming Reception – complimentary food/drinks will be served
Date: September 24th New York City (confirmed details below), October 13th in Boston, October 22nd in Los Angeles, and October 28th in San Francisco
Time: 3:30 p.m. to 5:30 p.m. local time Accredited Investor Only Roundtables, followed by 5:30 p.m. to 8:00 p.m. local time ‘Meet Your Match’ Welcoming Reception
Location and Agenda: Venue address and event agenda available upon RSVP (rsvp@Visionary.is)
Industries/Stages Represented by attending Visionary Members: Consumer, Entertainment, Health, Real Estate, Renewable Energy, Technology // Early, Growth, Public Company, Funds
2012pharmaceutical
sjwilliamspa